STRM Logo_Streamline Health_2C_Vertical.png
Streamline Health® To Report Third Quarter 2022 Financial Performance and Provide Corporate Update
07 déc. 2022 16h30 HE | Streamline Health Solutions, Inc.
Atlanta, GA, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to...
Primary Logo (Denarius) 2 Blue (002).png
Denarius Metals Announces Third Quarter and First Nine Months 2022 Results
28 nov. 2022 07h00 HE | Denarius Metals Corp.
TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Denarius Metals Corp. (“Denarius Metals” or “the Company”) (TSXV: DSLV; OTCQB: DNRSF) announced today that it has filed its unaudited interim condensed...
Logo.png
Viewbix Reports Third Quarter 2022 Financial Results with a 176% Growth in Revenues Totaling $66 Million
22 nov. 2022 16h10 HE | Viewbix Inc.
Viewbix reached an operating income of $1.4 million Amihay Hadad, Viewbix, CEO: “We entered the field of digital content through apurchase that has proven itself, financially and synergistic and it...
ARIDIS_LOGO.png
Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results and Business Update
21 nov. 2022 18h30 HE | Aridis Pharmaceuticals, Inc.
Top-line data from the Phase 3 clinical trial evaluating AR-301 for the treatment of VAP expected in December of this year LOS GATOS, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Aridis...
Logo.jpg
RYVYL Reports Third Quarter 2022 Financial Results
21 nov. 2022 16h15 HE | RYVYL Inc.
Third Quarter 2022 Highlighted by Strong Processing Volume Growth, Company Rebranding and Launch of coyni Platform SAN DIEGO, CA, Nov. 21, 2022 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL)...
BioStem Technologies Logo_CMYK_Color.jpg
BioStem Technologies Reports Third Quarter 2022 Operating and Financial Results
15 nov. 2022 16h05 HE | BioStem Technologies, Inc.
Company to Host a Conference Call and Webcast on November 15, 2022, at 4:30 pm EDT POMPANO BEACH, FLORIDA., Nov. 15, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading...
LOGO.jpg
QSAM Biosciences Reports Third Quarter 2022 Financial Results and Provides Corporate Update
15 nov. 2022 08h00 HE | QSAM Biosciences Inc.
Further Progress Demonstrated in Clinical Program Evaluating CycloSam® Radiopharmaceutical Drug Candidate for Treatment of Metastatic Bone Cancer AUSTIN, Texas, Nov. 15, 2022 (GLOBE...
Qualigen-Logo-Tag.png
Qualigen Therapeutics, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update
15 nov. 2022 07h30 HE | Qualigen Therapeutics, Inc.
Q3 2022 FastPack ® sales increased approximately 25% year-over-yearCompany continues to execute on and advance core therapeutic programs CARLSBAD, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Qualigen...
Omniq.png
OMNIQ REPORTS RECORD REVENUE OF $27M FOR Q3 2022 UP 32% OVER Q3 2021 AND RECORD 9 MONTH REVENUE OF $77.5M UP 45% OVER SAME PERIOD OF 2021. - Updated
14 nov. 2022 17h54 HE | OMNIQ Corp.
 SALT LAKE CITY, Nov. 14, 2022 (GLOBE NEWSWIRE) -- OMNIQ Corp. (NASDAQ: OMQS) (“OMNIQ” or “the Company”), a provider of Supply Chain and Artificial Intelligence (AI)-based solutions, today announced...
InterpaceBiosciences_New Logo.png
Interpace Biosciences Announces Third Quarter 2022 Financial and Business Results Sale of Pharma Significantly Improves Liquidity Resulting in Removal of Going Concern
14 nov. 2022 16h41 HE | Interpace Biosciences, Inc.
Q3 Revenue of $8.2 million up 2% versus Prior YearQ3 Adjusted EBITDA PositiveCash and Cash Equivalents total $6.3 million as of September 30, 2022 PARSIPPANY, NJ, Nov. 14, 2022 (GLOBE NEWSWIRE)...